Ocular Drug Delivery MCQs and Fill-in-the-Blanks
Uploaded by
Unknownto Be betterOcular Drug Delivery MCQs and Fill-in-the-Blanks
Uploaded by
Unknownto Be betterCommon questions
Powered by AIThe pH of eye drops should be maintained at 7.4 to match the natural pH of lachrymal fluid, ensuring comfort and reducing irritation upon application. Maintaining this pH is crucial as deviations can cause discomfort and affect the stability and solubility of the active ingredients .
Passive loading involves encapsulating drugs during liposome formation without the input of external energy, which can result in lower drug loading efficiency but is gentler on sensitive drugs. Active loading uses gradients or energy to actively load drugs post-formation, offering higher loading efficiencies and more controlled release profiles. The choice between them depends on the drug properties and desired therapeutic outcomes .
High density systems in GRDDS are designed to remain in the stomach by overcoming the natural gastric emptying. Their dense formulation helps them settle at the bottom of the gastric contents, providing prolonged local action and a steady release of the active pharmaceutical ingredient, which is beneficial for drugs with a narrow absorption window in the upper part of the gastrointestinal tract .
The cul-de-sac is an anatomical site in the eye where devices like Lacrisert, Minidisc, and SODI can be inserted. It acts as a reservoir that holds the suppository or insert, allowing for a slow and controlled release of the drug, enhancing therapeutic efficacy and patient compliance .
Liposomes can be prepared by methods such as ether injection, sonication, and extrusion. Each method has its own advantages: Ether injection provides a controlled environment for liposome formation, sonication facilitates the breakdown of large vesicles into smaller ones, and extrusion ensures uniform size distribution. The choice of method depends on the desired liposome characteristics and the application in drug delivery systems .
Copper-T IUDs, such as TCu-380A, operate by releasing copper ions that create an inhospitable environment for sperm. Challenges include potential discomfort, irritation, and expulsion issues. Considerations must include individualized patient assessments and counseling regarding potential side effects and expulsion risks .
Stealth liposomal technology, used in the formulation of drugs like Doxil, involves coating liposomes with polyethylene glycol (PEG), which extends their circulation time by evading the immune system. This technology enhances drug delivery efficiency, reduces toxicity, and improves therapeutic outcomes by targeting the drug more effectively to diseased sites .
The primary barrier in transdermal drug delivery is the stratum corneum, which limits penetration. Drugs must be formulated to enhance penetration, often requiring the use of non-polar substances that can undergo passive diffusion. Mechanisms like iontophoresis and microneedles are also employed to facilitate drug entry by temporarily disrupting the skin barrier .
In ocular drug delivery, a w/o (water-in-oil) emulsion might be preferred because it can provide a more prolonged retention on the eye surface due to the oil phase acting as a reservoir, reducing the need for frequent administration and improving drug bioavailability .
Niosomes are formulated using non-ionic surface active agents. These agents are chosen because they are less likely to cause irritation and are more stable, making them suitable for drug delivery applications .